Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:14 PM
Ignite Modification Date:
2025-12-24 @ 2:14 PM
NCT ID:
NCT03365895
Eligibility Criteria:
Inclusion Criteria:
* Be capable of understanding the investigational nature of the study and all pertinent aspects of the study
* Be capable of signing and providing written consent in accordance with institutional and federal guidelines
* Have a histologically-confirmed diagnosis of breast cancer
* Need to be treated with taxane containing chemotherapy as determined by their treating physician
* Be able to undergo magnetic resonance (MR) imaging
* Be willing and able to comply with scheduled visits, treatment plan, and MR imaging
Exclusion Criteria:
* Have non-MRI compatible metallic objects on/in body
* Have metallic hardware in the lower extremity which is MR compatible however would create too much artifact for MR examination
* Are unable to lay still in the MR scanner for length of examination
* Have severe claustrophobia
* Have pre-existing peripheral neuropathy from other medical conditions or due to cancer
* Have diagnosis of diabetes
* Pregnant patients
* Prior exposure to neurotoxic chemotherapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
21 Years
Study:
NCT03365895
Study Brief:
Protocol Section:
NCT03365895